Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract

Frontiers in Neuroscience

Volumn , Issue APR, 2011, Pages

  Buckinx, Roeland ^a   Adriaensen, Dirk ^a   Van Nassauw, Luc ^a   Timmermans, Jean Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Corticotrophin releasing factor; Gastrointestinal tract; Inflammation; Urocortin

Indexed keywords

AMINO ACID; CHEMOKINE; CHOLINE ACETYLTRANSFERASE; CLOSTRIDIUM DIFFICILE TOXIN A; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; DEXTRAN SULFATE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE RECEPTOR; PEPTIDOGLYCAN POLYSACCHARIDE; RNA; SEROTONIN; SOMATOSTATIN; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; AUTONOMIC NERVOUS SYSTEM; CELLULAR DISTRIBUTION; COLITIS; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; DISEASE CONTROL; ENDOCRINE CELL; ENTEROCHROMAFFIN CELL; ENTEROENDOCRINE CELL; GASTRITIS; GUINEA PIG; HELICOBACTER PYLORI; HUMAN; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VIVO STUDY; KNOCKOUT GENE; LAMINA PROPRIA; MAST CELL; MOTONEURON; MYENTERIC PLEXUS; NERVE CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSMOREGULATION; PHYLOGENY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STOMACH MUCOSA; STOMACH MUSCLE; TYPHLITIS; ULCERATIVE COLITIS;

EID: 84861839088     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2011.00054     Document Type: Review

References (122)

1. Anton, P. M., Gay, J., Mykoniatis, A., Pan, A., O'Brien, M., Brown, D., Karalis, K., and Pothoulakis, C. (2004). Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc. Natl. Acad. Sci. U.S.A. 101, 8503-8508.
2. Arai, M., Assil, I. Q., and Abou-Samra, A. B. (2001). Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 142, 446-454.
3. Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., and Watanabe, M. (2005). MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23.
4. Ardati, A., Goetschy, V., Gottowick, J., Henriot, S., Valdenaire, O., Deuschle, U., and Kilpatrick, G. J. (1999). Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology 38, 441-448.
5. Bale, T. L., Giordano, F. J., Hickey, R. P., Huang, Y., Nath, A. K., Peterson, K. L., Vale, W. W., and Lee, K. F. (2002). Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc. Natl. Acad. Sci. U.S.A. 99, 7734-7739.
6. Barreau, F., Cartier, C., Leveque, M., Ferrier, L., Moriez, R., Laroute, V., Rosztoczy, A., Fioramonti, J., and Bueno, L. (2007). Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J. Physiol. 580(Pt 1), 347-356.
7. Behan, D. P., De Souza, E. B., Lowry, P. J., Potter, E., Sawchenko, P., and Vale, W. W. (1995). Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front. Neuroendocrinol. 16, 362-382.
8. Bhatia, V., and Tandon, R. K. (2005). Stress and the gastrointestinal tract. J. Gastroenterol. Hepatol. 20, 332-339.
9. Bisschops, R., Vanden Berghe, P., Sarnelli, G., Janssens, J., and Tack, J. (2006). CRF-induced calcium signaling in guinea pig small intestine myenteric neurons involves CRF-1 receptors and activation of voltage-sensitive calcium channels. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1252-G1260.
10. Blank, T., Nijholt, I., Grammatopoulos, D. K., Randeva, H. S., Hillhouse, E. W., and Spiess, J. (2003). Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23, 700-707.
11. Brar, B. K., Chen, A., Perrin, M. H., and Vale, W. (2004). Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 145, 1718-1729.
12. Camara, R. J., Ziegler, R., Begre, S., Schoepfer, A. M., and von, K. R. (2009). The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion 80, 129-139.
13. Cantarella, G., Lempereur, L., Lombardo, G., Chiarenza, A., Pafumi, C., Zappala, G., and Bernardini, R. (2001). Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br. J. Pharmacol. 134, 837-844.
14. Cario, E., and Podolsky, D. K. (2005). Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol. Immunol. 42, 887-893.
15. Castagliuolo, I., Lamont, J. T., Qiu, B., Fleming, S. M., Bhaskar, K. R., Nikulasson, S. T., Kornetsky, C., and Pothoulakis, C. (1996). Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am. J. Physiol. 271(5 Pt 1), G884-G892.
16. Chang, J., Hoy, J. J., Idumalla, P. S., Clifton, M. S., Pecoraro, N. C., and Bhargava, A. (2007). Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 28, 1453-1460.
17. Chaniotou, Z., Giannogonas, P., Theoharis, S., Teli, T., Gay, J., Savidge, T., Koutmani, Y., Brugni, J., Kokkotou, E., Pothoulakis, C., and Karalis, K. P. (2010). Corticotropin-releasing factor regulates TLR4 expression in the colon and protects mice from colitis. Gastroenterology 139, 2083-2092.
18. Chatzaki, E., Charalampopoulos, I., Leontidis, C., Mouzas, I. A., Tzardi, M., Tsatsanis, C., Margioris, A. N., and Gravanis, A. (2003). Urocortin in human gastric mucosa: relationship to inflammatory activity. J. Clin. Endocrinol. Metab. 88, 478-483.
19. Chatzaki, E., Crowe, P. D., Wang, L., Million, M., Tache, Y., and Grigoriadis, D. E. (2004a). CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem. 90, 309-316.
20. Chatzaki, E., Murphy, B. J., Wang, L., Million, M., Ohning, G. V., Crowe, P. D., Petroski, R., Tache, Y., and Grigoriadis, D. E. (2004b). Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J. Neurochem. 88, 1-11.
21. Chatzaki, E., Lambropoulou, M., Constantinidis, T. C., Papadopoulos, N., Tache, Y., Minopoulos, G., and Grigoriadis, D. E. (2006). Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis. J. Cell. Physiol. 209, 905-911.
22. Chen, A., Blount, A., Vaughan, J., Brar, B., and Vale, W. (2004). Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology 145, 2445-2457.
23. Chen, A. M., Perrin, M. H., Digruccio, M. R., Vaughan, J. M., Brar, B. K., Arias, C. M., Lewis, K. A., Rivier, J. E., Sawchenko, P. E., and Vale, W. W. (2005). A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U.S.A. 102, 2620-2625.
24. Chevalier, J., Derkinderen, P., Gomes, P., Thinard, R., Naveilhan, P., Vanden Berghe, P., and Neunlist, M. (2008). Activity-dependent regulation of tyrosine hydroxylase expression in the enteric nervous system. J. Physiol. 586, 1963-1975.
25. Dautzenberg, F. M., Gutknecht, E., Van der Linden, I., Olivares-Reyes, J. A., Durrenberger, F., and Hauger, R. L. (2004a). Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells. Biochem. Pharmacol. 68, 1833-1844.
26. Dautzenberg, F. M., Higelin, J., Wille, S., and Brauns, O. (2004b). Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant. Regul. Pept. 121, 89-97.
27. Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., and Moreau, J. (2001). Molecular biology of the CRH receptors - in the mood. Peptides 22, 753-760.
28. De Jager, P. L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A., Libioulle, C., Jani, N., Dassopoulos, T., Bromfield, G. P., Dubois, B., Cho, J. H., Brant, S. R., Duerr, R. H., Yang, H., Rotter, J. I., Silverberg, M. S., Steinhart, A. H., Daly, M. J., Podolsky, D. K., Louis, E., Hafler, D. A., and Rioux, J. D. (2007). The role of the toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8, 387-397.
29. Eutamene, H., Theodorou, V., Fioramonti, J., and Bueno, L. (2003). Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J. Physiol. 553(Pt 3), 959-966.
30. Furness, J. B. (2006). The Enteric Nervous System. Oxford: Blackwell Publishing.
31. Furutani, Y., Morimoto, Y., Shibahara, S., Noda, M., Takahashi, H., Hirose, T., Asai, M., Inayama, S., Hayashida, H., Miyata, T., and Numa, S. (1983). Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor. Nature 301, 537-540.
32. Gallagher, J. P., Orozco-Cabal, L. F., Liu, J., and Shinnick-Gallagher, P. (2008). Synaptic physiology of central CRH system. Eur. J. Pharmacol. 583, 215-225.
33. Gay, J., Kokkotou, E., O'Brien, M., Pothoulakis, C., and Karalis, K. P. (2008). Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology 149, 3403-3409.
34. Gonzalez-Rey, E., Chorny, A., Varela, N., Robledo, G., and Delgado, M. (2006a). Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am. J. Pathol. 168, 1921-1930.
35. Gonzalez-Rey, E., Fernandez-Martin, A., Chorny, A., and Delgado, M. (2006b). Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 55, 824-832.
36. Greenwood-Van Meerveld, B., Johnson, A. C., Cochrane, S., Schulkin, J., and Myers, D. A. (2005). Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol. Motil. 17, 415-422.
37. Gross, K. J., and Pothoulakis, C. (2007). Role of neuropeptides in inflammatory bowel disease. Inflamm. Bowel Dis. 13, 918-932.
38. Gutknecht, E., Van der Linden, I., Van Kolen, K., Verhoeven, K. F., Vauquelin, G., and Dautzenberg, F. M. (2009). Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. Mol. Pharmacol. 75, 648-657.
39. Gutknecht, E., Vauquelin, G., and Dautzenberg, F. M. (2010). Corticotropin-releasing factor receptors induce calcium mobilization through cross-talk with Gq-coupled receptors. Eur. J. Pharmacol. 642, 1-9.
40. Harada, S., Imaki, T., Naruse, M., Chikada, N., Nakajima, K., and Demura, H. (1999). Urocortin mRNA is expressed in the enteric nervous system of the rat. Neurosci. Lett. 267, 125-128.
41. Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W. W., and Dautzenberg, F. M. (2003). International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 55, 21-26.
42. Hillhouse, E. W., and Grammatopoulos, D. K. (2006). The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 27, 260-286.
43. Hisamatsu, T., Inoue, N., Yajima, T., Izumiya, M., Ichikawa, H., and Hibi, T. (2007). Psychological aspects of inflammatory bowel disease. J. Gastroenterol. 42(SUPPL. 17), 34-40.
44. Hsu, S. Y., and Hsueh, A. J. (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611.
45. Ichikawa, T., McMaster, D., Lederis, K., and Kobayashi, H. (1982). Isolation and amino acid sequence of urotensin I, a vasoactive and ACTH-releasing neuropeptide, from the carp (Cyprinus carpio) urophysis. Peptides 3, 859-867.
46. Im, E., Rhee, S. H., Park, Y. S., Fiocchi, C., Tache, Y., and Pothoulakis, C. (2010). Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. Gastroenterology 138, 2457-2467.
47. Karteris, E., Markovic, D., Chen, J., Hillhouse, E. W., and Grammatopoulos, D. K. (2010). Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone. Endocrinology 151, 4959-4968.
48. Kawahito, Y., Sano, H., Kawata, M., Yuri, K., Mukai, S., Yamamura, Y., Kato, H., Chrousos, G. P., Wilder, R. L., and Kondo, M. (1994). Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology 106, 859-865.
49. Kawahito, Y., Sano, H., Mukai, S., Asai, K., Kimura, S., Yamamura, Y., Kato, H., Chrousos, G. P., Wilder, R. L., and Kondo, M. (1995). Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37, 544-551.
50. Kiank, C., Tache, Y., and Larauche, M. (2010). Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav. Immun. 24, 41-48.
51. Kimura, T., Amano, T., Uehara, H., Ariga, H., Ishida, T., Torii, A., Tajiri, H., Matsueda, K., and Yamato, S. (2007). Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G903-G910.
52. Kokkotou, E., Torres, D., Moss, A. C., O'Brien, M., Grigoriadis, D. E., Karalis, K., and Pothoulakis, C. (2006). Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J. Immunol. 177, 3355-3361.
53. Kostich, W. A., Chen, A., Sperle, K., and Largent, B. L. (1998). Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12, 1077-1085.
54. Kozicz, T., and Arimura, A. (2002). Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23, 515-521.
55. Kyrou, I., and Tsigos, C. (2009). Stress hormones: physiological stress and regulation of metabolism. Curr. Opin. Pharmacol. 9, 787-793.
56. la Fleur, S. E., Wick, E. C., Idumalla, P. S., Grady, E. F., and Bhargava, A. (2005). Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc. Natl. Acad. Sci. U.S.A. 102, 7647-7652.
57. Lakshmanan, J., Magee, T. R., Richard, J. D., Liu, G. L., Salido, E., Sugano, S. K., Ferrini, M., and Ross, M. G. (2008). Localization and gestation-dependent pattern of corticotrophin-releasing factor receptor subtypes in ovine fetal distal colon. Neurogastroenterol. Motil. 20, 1328-1339.
58. Larauche, M., Kiank, C., and Tache, Y. (2009). Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J. Physiol. Pharmacol. 60(Suppl. 7), 33-46.
59. Lederis, K., Letter, A., McMaster, D., Moore, G., and Schlesinger, D. (1982). Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science 218, 162-165.
60. Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J., Sawchenko, P. E., and Vale, W. W. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7570-7575.
61. Liu, S., Gao, N., Hu, H. Z., Wang, X., Wang, G. D., Fang, X., Gao, X., Xia, Y., and Wood, J. D. (2006). Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system. J. Comp. Neurol. 494, 63-74.
62. Liu, S., Gao, X., Gao, N., Wang, X., Fang, X., Hu, H. Z., Wang, G. D., Xia, Y., and Wood, J. D. (2005). Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. J. Comp. Neurol. 481, 284-298.
63. Liu, S., Ren, W., Qu, M. H., Bishop, G. A., Wang, G. D., Wang, X. Y., Xia, Y., and Wood, J. D. (2010). Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br. J. Pharmacol. 159, 222-236.
64. Lovejoy, D. A. (2009). Structural evolution of urotensin-I: reflections of life before corticotropin releasing factor. Gen. Comp. Endocrinol. 164, 15-19.
65. Lovejoy, D. A., and Balment, R. J. (1999). Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen. Comp. Endocrinol. 115, 1-22.
66. Lovejoy, D. A., and Jahan, S. (2006). Phylogeny of the corticotropin-releasing factor family of peptides in the metazoa. Gen. Comp. Endocrinol. 146, 1-8.
67. Lovenberg, T. W., Chalmers, D. T., Liu, C., and De Souza, E. B. (1995a). CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136, 4139-4142.
68. Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., and Oltersdorf, T. (1995b). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 92, 836-840.
69. Maillot, C., Million, M., Wei, J. Y., Gauthier, A., and Tache, Y. (2000). Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 119, 1569-1579.
70. Mancinelli, R., Azzena, G. B., Diana, M., Forgione, A., and Fratta, W. (1998). In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility. J. Auton. Pharmacol. 18, 319-324.
71. Martinez, V., Wang, L., Rivier, J. E., Vale, W., and Tache, Y. (2002). Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 301, 611-617.
72. Mawdsley, J. E., and Rampton, D. S. (2005). Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481-1491.
73. Million, M., Grigoriadis, D. E., Sullivan, S., Crowe, P. D., Mcroberts, J. A., Zhou, H., Saunders, P. R., Maillot, C., Mayer, E. A., and Tache, Y. (2003). A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res. 985, 32-42.
74. Million, M., Wang, L., Wang, Y., Adelson, D. W., Yuan, P. Q., Maillot, C., Coutinho, S. V., Mcroberts, J. A., Bayati, A., Mattsson, H., Wu, V., Wei, J. Y., Rivier, J., Vale, W., Mayer, E. A., and Tache, Y. (2006). CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 55, 172-181.
75. Moss, A. C., Anton, P., Savidge, T., Newman, P., Cheifetz, A. S., Gay, J., Paraschos, S., Winter, M. W., Moyer, M. P., Karalis, K., Kokkotou, E., and Pothoulakis, C. (2007). Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut 56, 1210-1217.
76. Muramatsu, Y., Fukushima, K., Iino, K., Totsune, K., Takahashi, K., Suzuki, T., Hirasawa, G., Takeyama, J., Ito, M., Nose, M., Tashiro, A., Hongo, M., Oki, Y., Nagura, H., and Sasano, H. (2000). Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21, 1799-1809.
77. Musial, F., Hauser, W., Langhorst, J., Dobos, G., and Enck, P. (2008). Psychophysiology of visceral pain in IBS and health. J. Psychosom. Res. 64, 589-597.
78. Nozu, T., Martinez, V., Rivier, J., and Tache, Y. (1999). Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Am. J. Physiol. 276(4 Pt 1), G867-G874.
79. O'malley, D., Dinan, T. G., and Cryan, J. F. (2010a). Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides 31, 662-670.
80. O'malley, D., Julio-Pieper, M., Gibney, S. M., Gosselin, R. D., Dinan, T. G., and Cryan, J. F. (2010b). Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterol. Motil. 22, 301-311.
81. Okada, R., Ito, Y., Kaneko, M., Yamamoto, K., Chartrel, N., Conlon, J. M., Vaudry, H., and Kikuyama, S. (2005). Frog corticotropin-releasing hormone (CRH): isolation, molecular cloning, and biological activity. Ann. N. Y. Acad. Sci. 1040 150-155.
82. Okawara, Y., Morley, S. D., Burzio, L. O., Zwiers, H., Lederis, K., and Richter, D. (1988). Cloning and sequence analysis of cDNA for corticotropin-releasing factor precursor from the teleost fish Catostomus commersoni. Proc. Natl. Acad. Sci. U.S.A. 85, 8439-8443.
83. Palchaudhuri, M. R., Hauger, R. L., Wille, S., Fuchs, E., and Dautzenberg, F. M. (1999). Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J. Neuroendocrinol. 11, 419-428.
84. Pappas, T., Debas, H., and Tache, Y. (1985). Corticotropin-releasing factor inhibits gastric emptying in dogs. Regul. Pept. 11, 193-199.
85. Perrin, M., Donaldson, C., Chen, R., Blount, A., Berggren, T., Bilezikjian, L., Sawchenko, P., and Vale, W. (1995). Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U.S.A. 92, 2969-2973.
86. Pisarchik, A., and Slominski, A. (2004). Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur. J. Biochem. 271, 2821-2830.
87. Porcher, C., Juhem, A., Peinnequin, A., Sinniger, V., and Bonaz, B. (2005). Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1091-G1103.
88. Porcher, C., Peinnequin, A., Pellissier, S., Meregnani, J., Sinniger, V., Canini, F., and Bonaz, B. (2006). Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Peptides 27, 1464-1475.
89. Qu, Z. D., Thacker, M., Castelucci, P., Bagyanszki, M., Epstein, M. L., and Furness, J. B. (2008). Immunohistochemical analysis of neuron types in the mouse small intestine. Cell Tissue Res. 334, 147-161.
90. Rakoff-Nahoum, S., Hao, L., and Medzhitov, R. (2006). Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25, 319-329.
91. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
92. Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., and Sawchenko, P. E. (2001). Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848.
93. Rivier, J., Spiess, J., and Vale, W. (1983). Characterization of rat hypothalamic corticotropin-releasing factor. Proc. Natl. Acad. Sci. U.S.A. 80, 4851-4855.
94. Saffran, M., and Schally, A. V. (1955). The release of corticotrophin by anterior pituitary tissue in vitro. Can. J. Biochem. Physiol. 33, 408-415.
95. Sand, E., Themner-Persson, A., and Ekblad, E. (2010). Corticotropin releasing factor-distribution in rat intestine and role in neuroprotection. Regul. Pept. 166, 68-75.
96. Santos, J., Saunders, P. R., Hanssen, N. P., Yang, P. C., Yates, D., Groot, J. A., and Perdue, M. H. (1999). Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am. J. Physiol. 277(2 Pt 1), G391-G399.
97. Saruta, M., Takahashi, K., Suzuki, T., Fukuda, T., Torii, A., and Sasano, H. (2005). Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides 26, 1196-1206.
98. Saruta, M., Takahashi, K., Suzuki, T., Torii, A., Kawakami, M., and Sasano, H. (2004). Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J. Clin. Endocrinol. Metab. 89, 5352-5361.
99. Saunders, P. R., Santos, J., Hanssen, N. P., Yates, D., Groot, J. A., and Perdue, M. H. (2002). Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig. Dis. Sci. 47, 208-215.
100. Seasholtz, A. F., Bourbonais, F. J., Harnden, C. E., and Camper, S. A. (1991). Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene. Mol. Cell. Neurosci. 2, 266-273.
101. Shibahara, S., Morimoto, Y., Furutani, Y., Notake, M., Takahashi, H., Shimizu, S., Horikawa, S., and Numa, S. (1983). Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J. 2, 775-779.
102. Stenzel-Poore, M. P., Heldwein, K. A., Stenzel, P., Lee, S., and Vale, W. W. (1992). Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Mol. Endocrinol. 6, 1716-1724.
103. Teitelbaum, A. A., Gareau, M. G., Jury, J., Yang, P. C., and Perdue, M. H. (2008). Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G452-G459.
104. Thompson, R. C., Seasholtz, A. F., and Herbert, E. (1987). Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol. Endocrinol. 1, 363-370.
105. Tsatsanis, C., Androulidaki, A., Alissafi, T., Charalampopoulos, I., Dermitzaki, E., Roger, T., Gravanis, A., and Margioris, A. N. (2006). Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J. Immunol. 176, 1869-1877.
106. Tsatsanis, C., Androulidaki, A., Dermitzaki, E., Charalampopoulos, I., Spiess, J., Gravanis, A., and Margioris, A. N. (2005). Urocortin 1 and urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett. 579, 4259-4264.
107. Tsatsanis, C., Androulidaki, A., Dermitzaki, E., Gravanis, A., and Margioris, A. N. (2007). Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J. Cell. Physiol. 210, 774-783.
108. Valdenaire, O., Giller, T., Breu, V., Gottowik, J., and Kilpatrick, G. (1997). A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim. Biophys. Acta 1352, 129-132.
109. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
110. Van Kolen, K., Dautzenberg, F. M., Verstraeten, K., Royaux, I., De, H. R., Gutknecht, E., and Peeters, P. J. (2010). Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2. Neuropharmacology 58, 135-144.
111. van Tol, E. A., Petrusz, P., Lund, P. K., Yamauchi, M., and Sartor, R. B. (1996). Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats. Gut 39, 385-392.
112. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., and Rivier, C. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292.
113. Wallon, C., Yang, P. C., Keita, A. V., Ericson, A. C., McKay, D. M., Sherman, P. M., Perdue, M. H., and Soderholm, J. D. (2008). Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 57, 50-58.
114. Wang, L., Martinez, V., Rivier, J. E., and Tache, Y. (2001). Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1401-R1410.
115. Wlk, M., Wang, C. C., Venihaki, M., Liu, J., Zhao, D., Anton, P. M., Mykoniatis, A., Pan, A., Zacks, J., Karalis, K., and Pothoulakis, C. (2002). Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 123, 505-515.
116. Wolter, H. J. (1984). Corticotropin-releasing factor is contained within perikarya and nerve fibres of rat duodenum. Biochem. Biophys. Res. Commun. 122, 381-387.
117. Wu, S. V., Yuan, P. Q., Lai, J., Wong, K., Chen, M. C., Ohning, G. V., and Tache, Y. (2011). Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: an enterochromaffin cell model. Endocrinology 152, 126-137.
118. Wu, S. V., Yuan, P. Q., Wang, L., Peng, Y. L., Chen, C. Y., and Tache, Y. (2007). Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 148, 1675-1687.
119. Yuan, P. Q., Million, M., Wu, S. V., Rivier, J., and Tache, Y. (2007). Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol. Motil. 19, 923-936.
120. Yuan, P. Q., Wu, S. V., Wang, L., and Tache, Y. (2010). Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides 31, 322-331.
121. Zijdenbos, I. L., de Wit, N. J., van der Heijden, G. J., Rubin, G., and Quartero, A. O. (2009). Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst. Rev. CD006442.
122. Zmijewski, M. A., and Slominski, A. T. (2010). Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim. Pol. 57, 1-13.